IV drips marketed for “detox” contained toxins; dozens injured

Details

Intravenous drips advertised as detoxification treatments were reportedly packed with toxic substances and have led to poisonings among dozens of patients. The available information indicates that the IV solutions did not contain ingredients appropriate for safe intravenous use in these therapies.

One of the identified substances was glutathione, and it was noted that the form present was not intended for injection. This detail suggests that at least some components of the drips were unsuitable for the method of administration being used.

As a result of receiving these infusions, dozens of people were harmed. The source material does not provide specific numbers, locations, dates, or information on the clinical care provided to those affected.

There is no information in the provided material about the clinics, suppliers, or individuals responsible for the drips, nor about any investigations or regulatory actions taken. Given the absence of such facts, no further conclusions or assumptions are made here.

The remaining details do not clarify whether other products are implicated or whether the issue is widespread. Without additional information, the scope and long-term implications of the incident cannot be determined.